Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that asystole occurred for the patient for one second when system diagnostics was performed right after wound closure.Once the system diagnostics test completed, the patient's heart rate recovered.Prior to that, no problem had occurred when a stimulation test was performed before the wound closure.The physician lowered the patient's pulsewidth from 500usec to 250usec and multiple system diagnostic test were performed at various output currents.For 0.25ma and 0.5 ma, there were no issues seen but for 0.75ma and 1 ma the patient's heart rate slowed down a bit.Since no further events of cardiac arrest/asystole occurred, the physician concluded that the vns was usable as long as the output current was set to 1ma or below.No device malfunction was suspected.No other relevant information has been received to date.
|